SJ Medical
SJ Medical
The Marshall Islands (RMI), a sovereign Micronesian nation, is currently navigating a critical transition in its healthcare landscape. As a market characterized by unique logistical challenges and a high prevalence of non-communicable diseases (NCDs), particularly Type II diabetes and associated Peripheral Artery Disease (PAD), the demand for Atherectomy Systems has shifted from a luxury to a clinical necessity. Our role as a premier factory and exporter is to bridge the gap between advanced manufacturing and the localized needs of the Pacific island region.
Historically, the Marshall Islands healthcare system, centered around Majuro and Ebeye, has relied heavily on medical referrals to Hawaii or the Philippines for complex vascular procedures. However, a "Localized Healthcare Resilience" initiative is currently underway. By integrating minimally invasive atherectomy technologies, the RMI healthcare infrastructure can treat severely calcified arterial lesions locally, reducing the economic burden of patient off-island transfers.
The global atherectomy market is pivoting towards "Precision Debulking." In the Marshall Islands market, we are seeing three major trends:
Hangzhou SJ Medical Co., Ltd. was established in 2015 and is dedicated to the research, development, manufacturing, and commercialization of vascular interventional medical devices. The company focuses on both cardiovascular and peripheral intervention fields, striving to provide safe, reliable, and innovative solutions for healthcare providers worldwide.
Over the years, SJ Medical has developed a comprehensive product portfolio covering key areas of vascular intervention. Its offerings span from various types of balloon catheters for coronary and peripheral applications to supporting access and diagnostic devices, as well as advanced stent systems.
Contact Our Experts
SJ Medical operates a modern manufacturing facility with a total area of approximately 5,000 square meters, featuring a million-class clean workshop.
Our technical team includes senior engineers with decades of experience in vascular intervention, maintaining strict quality control.
Specialized shipping routes to the Marshall Islands, ensuring cold-chain integrity and regulatory compliance (CE, ISO 13485, CFDA).
SJ Medical focuses on the development of vascular interventional devices designed for both coronary and peripheral procedures. Its product range integrates interventional access systems, diagnostic catheters, and therapeutic devices, forming a complete solution for minimally invasive vascular treatments. Each product is developed with an emphasis on precision, safety, and clinical performance, aiming to support physicians in achieving optimal procedural outcomes.
Regulatory Assistance: We provide full documentation for RMI Ministry of Health (MOH) registration, including Free Sale Certificates and CE documentation.
Logistics Optimization: Direct sea-freight and air-cargo solutions to Majuro Port and Amata Kabua International Airport.
Clinical Training: Remote and on-site training for Marshallese clinicians on the use of atherectomy catheters and balloon systems.
Given the high incidence of calcified PAD in the region, orbital and rotational atherectomy systems that use high-torque wires are most effective. Our introducer sheaths and balloon catheters are designed to support these high-precision systems.
Yes, we are a leading factory providing full-spectrum OEM services, from component manufacturing (like copper clad steel wires) to complete catheter assemblies with custom branding.
All products are vacuum-sealed in medical-grade Tyvek packaging and shipped in reinforced, climate-controlled containers to prevent any humidity or temperature-related degradation.
